A new fingerprint matching algorithm developed by Precise Biometrics delivers significantly higher accuracy, along with stronger security and easier use.

Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce, further to its ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) ...

Explore how AI assistants in 2025 used persistent memory, proactive guidance, cross-device reach, and DPDP regulation in ...

Generative AI in advertising is stirring controversy, as seen in recent McDonald's and Coca-Cola campaigns that sparked ...

The Cyber Threat Observatory reports that Common Vulnerability Exposures linked to identity systems have surged by 300 ...

Onconic Therapeutics announced on December 11 that it has been officially invited for the second consecutive year to participate in the '2026 JP ...

Cirius Therapeutics, Inc., a developer of innovative therapies for people suffering from diseases driven by insulin resistance and metabolic dysfunction, announced today that Robert Beardsley, PhD, ...

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2026 beginning at 8:00 a.m. ET and lasting approximately ...

RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...